Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 September 2021 | Story Nonsindiso Qwabe
“This way please” UFS Clinic nurses point the way. From left to right: Sister Nangamso Lukhubeni, Sister Noluthando Luthuli, Sister Mathapelo Moloi, and Sister Modiehi Moloi.

Fully vaccinated! 

These were the words uttered by many Qwaqwa staff members who received their second Pfizer jab at the vaccination site on the Qwaqwa Campus on Thursday (2 September 2021). More than 100 staff members turned up at the site, many for the second jab, while others were there to get their first. The staff members were full of praise for the convenience of having a site on campus, and said the brisk service made the entire process a breeze. The 24/7 Study Centre on campus was repurposed as a vaccination site at the end of August, bringing much-needed relief to staff and students, as well as the Qwaqwa community.

The vaccination experience

Chelly König, Professional Officer in the Department of Chemistry, urged people to trust the science behind the vaccine and the fact that it works. König also came with her relatives. “I’m fully vaccinated and feeling fantastic. I’d urge anyone who’s still hesitant to trust the sciences; these people know what they are doing. My aunt, who is 62, developed COVID-19 after getting her two jabs, and she didn’t experience any effects at all. It was just like the flu. Seeing her recovery convinced me that the vaccine works.”

Ntswaki Mokoena of Bidvest Prestige Cleaning Services also received her second jab. She said: “I am fully vaccinated and so happy. I’ve experienced no side effects whatsoever, and I encourage people to vaccinate; the vaccine is harmless. They should not listen to naysayers who haven’t even vaccinated.”

Calling on more people to vaccinate 

Sister Mathapelo Moloi, Chief Officer at the campus clinic, said the vaccination drive was a source of pride for the campus. “Our priority is to re-open the campus, so I’m very happy that we are seeing staff and students being willing to get vaccinated.”

“It’s not the first time that there has been hesitancy around the vaccine. Providing information is our priority – to help them understand the side effects and everything pertaining to the vaccine.”

Acting Director of Student Affairs on Qwaqwa Campus, Zakhele Mdluli, said vaccinations would help the university community get back to normal. “I encourage students to get vaccinated so that they are able to come back to campus knowing that everyone is safe. This vaccination is no different from the vaccinations we used to get when we were younger.”

The centre operates Monday to Friday from 08:00 to 15:00. People can pre-register either online at https://vaccine.enroll.health.gov.za or via WhatsApp on +27 0 60 012 3456 and should bring along their identity documents. The site is open to anyone 18 years and older. They can simply walk in – no bookings are required.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept